Vigabatrin for focal drug delivery in epilepsy: Bilateral microinfusion into the subthalamic nucleus is more effective than intranigral or systemic administration in a rat seizure model-Reference-Cited by-同舟云学术

Vigabatrin for focal drug delivery in epilepsy: Bilateral microinfusion into the subthalamic nucleus is more effective than intranigral or systemic administration in a rat seizure model

Published:2012-05 Issue:2 Volume:46 Page:362-376
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Bröer Sonja,Backofen-Wehrhahn Bianca,Bankstahl Marion,Gey Laura,Gernert Manuela,Löscher Wolfgang

Funder

Deutsche Forschungsgemeinschaft (Bonn, Germany)

Publisher

Elsevier BV

Subject

Neurology

Reference83 articles.

1. Neuromodulation in epilepsy;Al-Otaibi;Neurosurgery,2011

2. Cellular correlate of assembly formation in oscillating hippocampal networks in vitro;Bähner;Proc. Natl. Acad. Sci. U. S. A.,2011

3. Future prospects of brain stimulation;Benabid;Neurol. Res.,2000

4. Antiepileptic drug therapy the story so far;Brodie;Seizure,2010

5. Intracerebral injection of gamma vinyl GABA: method for measuring rates of GABA synthesis in specific brain regions in vivo;Casu;Life Sci.,1981

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic intermittent convection-enhanced delivery of vigabatrin to the bilateral subthalamic nucleus in an acute rat seizure model;Epilepsy Research;2024-01

2. Long-lasting antiseizure effects of chronic intrasubthalamic convection-enhanced delivery of valproate;Neurobiology of Disease;2023-10

3. Identification of New Antiseizure Medication Candidates in Preclinical Animal Studies;International Journal of Molecular Sciences;2023-08-24

4. Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies;Journal of Medicinal Chemistry;2023-04-04

5. Acute and chronic convection-enhanced muscimol delivery into the rat subthalamic nucleus induces antiseizure effects associated with high responder rates;Epilepsy Research;2023-02